Krishi offers a diagnostic platform utilizing the SHERPA™ Vision and SHERPA™ Chip technologies to provide lab-accurate antibiotic guidance for urinary tract and skin infections in dogs and cats within one hour. This solution enhances treatment accuracy from the outset, improving patient recovery while promoting responsible antibiotic use in veterinary practices.
Funding
Funding not disclosed
Founders
Product
Problem
Veterinary practices often face delays in obtaining lab results for bacterial infections in pets, leading to empirical antibiotic prescriptions that may be ineffective or contribute to antimicrobial resistance. Traditional laboratory testing can take several days, prolonging patient discomfort and potentially requiring multiple treatment adjustments.
Solution
Krishi Diagnostics offers the SHERPA™ platform, an in-clinic diagnostic tool that delivers lab-accurate antibiotic guidance for urinary tract and skin infections in dogs and cats within one hour. The platform consists of the SHERPA™ Vision, a reusable IoT-connected device with integrated heater and imager, and the SHERPA™ Chip, a consumable test containing all necessary reagents. By providing rapid, on-demand molecular insights, the SHERPA™ platform enables veterinarians to prescribe targeted antibiotic treatments from the outset, improving patient recovery and promoting responsible antibiotic use.
Target Audience
The primary target audience includes veterinary clinics and hospitals that treat companion animals, specifically dogs and cats, for bacterial infections.
Features
- Rapid results in approximately one hour, enabling immediate treatment decisions
- Lab-accurate antibiotic guidance for urinary tract and skin infections
- SHERPA™ Vision: Reusable, IoT-connected device with integrated heater and imager
- SHERPA™ Chip: Consumable test with embedded reagents; requires only sample addition
- Supports antimicrobial stewardship by facilitating targeted antibiotic prescriptions